OGEN
Income statement / Annual
Last year (2025), Oragenics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Oragenics Inc's net income was -$9.84 M.
See Oragenics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$22.11 M
|
$62.62 K
|
$30.11 K
|
$65.80 K
|
$75.04 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$22.11 M
|
-$62.62 K
|
-$30.11 K
|
-$65.80 K
|
-$75.04 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.39 B
|
$4.11 M
|
$15.49 M
|
$10.07 M
|
$10.59 M
|
$22.11 M
|
$12.12 M
|
$5.97 M
|
$3.54 M
|
$4.75 M
|
| General & Administrative Expenses |
$6.97 B
|
$6.44 M
|
$5.45 M
|
$4.48 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.97 B
|
$6.44 M
|
$5.45 M
|
$4.48 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
| Other Expenses |
-$9.35 B
|
$0.00
|
-$37.65 K
|
-$131.52 K
|
-$86.99 K
|
-$22.11 M
|
$2.00 K
|
$446.00
|
-$3.10 K
|
-$4.80 K
|
| Operating Expenses |
$9.36 M
|
$10.56 M
|
$20.90 M
|
$14.42 M
|
$15.77 M
|
$4.53 M
|
$15.88 M
|
$10.00 M
|
$6.72 M
|
$8.54 M
|
| Cost And Expenses |
$9.36 M
|
$10.56 M
|
$20.90 M
|
$14.42 M
|
$15.77 M
|
$26.64 M
|
$15.88 M
|
$10.00 M
|
$6.72 M
|
$8.54 M
|
| Interest Income |
$182.23 K
|
$45.90 K
|
$210.39 K
|
$135.90 K
|
$75.85 K
|
$89.29 K
|
$320.01 K
|
$86.53 K
|
$10.22 K
|
$40.09 K
|
| Interest Expense |
$785.93 K
|
$29.83 K
|
$30.59 K
|
$15.10 K
|
$15.76 K
|
$10.69 K
|
$7.30 K
|
$5.79 K
|
$216.33 K
|
$4.12 K
|
| Depreciation & Amortization |
$771.44 M
|
$0.00
|
$27.39 K
|
$44.67 K
|
$41.24 K
|
$51.71 K
|
$62.62 K
|
$30.11 K
|
$65.80 K
|
$75.04 K
|
| EBITDA |
$762.24 M |
-$10.54 M |
-$20.60 M |
-$14.23 M |
-$15.65 M |
-$26.59 M |
-$15.50 M |
-$9.88 M |
-$6.45 M |
-$8.42 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$616.89 K
|
-$9.10 K
|
$249.17 K
|
$132.38 K
|
$59.40 K
|
$210.76 K
|
$311.57 K
|
$80.00 K
|
-$13.21 K
|
$45.19 K
|
| Income Before Tax |
-$9.98 M
|
-$10.57 M
|
-$20.66 M
|
-$14.29 M
|
-$15.71 M
|
-$26.43 M
|
-$15.57 M
|
-$9.91 M
|
-$6.73 M
|
-$8.50 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$136.91 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.76 K
|
-$80.00 K
|
$13.21 K
|
$0.00
|
| Net Income |
-$9.84 M
|
-$10.57 M
|
-$20.66 M
|
-$14.29 M
|
-$15.71 M
|
-$26.43 M
|
-$15.57 M
|
-$9.91 M
|
-$6.73 M
|
-$7.01 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-4.56 |
-1.6 |
-9.18 |
-7.11 |
-8.09 |
-28.05 |
-22.1 |
-45.62 |
-81.99 |
-94.35 |
| EPS Diluted |
-4.56 |
-1.6 |
-9.18 |
-7.11 |
-8.09 |
-28.05 |
-22.1 |
-45.62 |
-81.99 |
-94.33 |
| Weighted Average Shares Out |
$2.16 M
|
$6.62 M
|
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942.19 K
|
$704.73 K
|
$217.32 K
|
$82.10 K
|
$74.33 K
|
| Weighted Average Shares Out Diluted |
$2.16 M
|
$6.62 M
|
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942.19 K
|
$704.73 K
|
$217.32 K
|
$82.10 K
|
$74.35 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
